BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 26651959)

  • 1. Fate of aortic bioprostheses: An 18-year experience.
    Piccardo A; Blossier JD; Le Guyader A; Orsel I; Sekkal S; Cornu E; Laskar M
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):754-761.e1. PubMed ID: 26651959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural valve deterioration of the Labcor Dokimos aortic prosthesis: a single-centre experience.
    Iskandarani D; Chaabo O; Gharzeddine W; Sfeir P; Obeid M; Ghazzal Z; Rebeiz A; Sawaya FJ
    Interact Cardiovasc Thorac Surg; 2022 Jun; 34(6):966-973. PubMed ID: 34687533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-term outcomes and hemodynamic performance of the St Jude Medical Epic aortic bioprosthesis for severe aortic stenosis.
    Wakami T; Fukunaga N; Shimoji A; Maeda T; Mori O; Yoshizawa K; Tamura N
    J Artif Organs; 2024 Jun; 27(2):125-130. PubMed ID: 37291209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term valve performance of St Jude Medical Epic porcine bioprosthesis in aortic position.
    Shibata K; Maeda S; Kashiyama N; Nakatsuji H; Ryugo M; Tsutsumi Y; Monta O
    J Artif Organs; 2024 Jun; 27(2):131-137. PubMed ID: 37099052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year clinical and echocardiographic follow-up of third-generation biological prostheses in the aortic position.
    Francica A; Benvegnù L; San Biagio L; Tropea I; Luciani GB; Faggian G; Onorati F
    J Thorac Cardiovasc Surg; 2024 May; 167(5):1705-1713.e8. PubMed ID: 36404144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the Surgical Technique With the Structural Valve Deterioration of a Bioprosthesis: A Prospective Cohort Study.
    Escalera A; Pascual I; Hernandez-Vaquero D; Formica F; Casares J; Diaz R; Alvarez R; Callejo F; Morales C; Moris C; Silva J
    Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):647-655. PubMed ID: 35777692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term echocardiographic data, mechanisms of failure, and reintervention outcomes of the Epic valve in mitral position-a large observational cohort.
    Bernard J; Kalavrouziotis D; Salaun E; Babaki S; Clavel MA; Rodés-Cabau J; Pibarot P; Mohammadi S
    J Thorac Cardiovasc Surg; 2023 Dec; 166(6):1644-1655.e7. PubMed ID: 37423547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-year experience following aortic valve replacement in patients younger than 60 years of age.
    Imamura Y; Kowatari R; Koizumi J; Tabayashi A; Saitoh D; Kin H
    J Cardiothorac Surg; 2024 May; 19(1):279. PubMed ID: 38715032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of bioprosthetic valves in the mitral position a systematic review of studies published over the last 20 years.
    Koulouroudias M; Di Mauro M; Lorusso R
    Eur J Cardiothorac Surg; 2023 Nov; 64(5):. PubMed ID: 37963023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial Microparticles: Markers of Inflammatory Response After Sutureless Valve Implantation.
    Oliveira JLR; Santos MAD; Timerman A
    Braz J Cardiovasc Surg; 2023 Oct; 39(1):e20230111. PubMed ID: 37889214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late clinical and echocardiographic results with the Magna Ease© pericardial aortic bioprosthesis.
    Anselmi A; Aymami M; Tomasi J; D'Alessandro G; Langanay T; Corbineau H; Mancini J; Flecher E; Verhoye JP
    Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38001032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful valve-in-valve replacement using intravascular lithotripsy for femoral access in an elderly patient with critical aortic stenosis and extensive vascular calcification.
    Rivero-Santana B; Galeote G; Jurado-Roman A; Jiménez-Valero S; Gonzálvez-García A; Moreno R
    J Invasive Cardiol; 2024 May; ():. PubMed ID: 38776474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid-deployment aortic valve replacement during challenging aortic valve reoperation: a case report.
    Mennander A; Saranko A; Kohonen M
    J Surg Case Rep; 2023 Oct; 2023(10):rjad614. PubMed ID: 37942347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discussion to: Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis.
    J Thorac Cardiovasc Surg; 2023 Dec; ():. PubMed ID: 38069984
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitroflow Pericardial Bioprosthesis: Can a Bad Reputation Be Mitigated?
    Bortolotti U
    Ann Thorac Surg; 2024 Mar; 117(3):663-664. PubMed ID: 37827351
    [No Abstract]   [Full Text] [Related]  

  • 16. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
    Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early haemodynamic performance of a latest generation supra-annular aortic bioprosthesis: experience from a large single-centre series.
    Deutsch MA; Prinzing A; Fiegl K; Wottke M; Badiu CC; Krane M; Goppel G; Bleiziffer S; Guenzinger R; Lange R
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1691-8. PubMed ID: 26656235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter aortic valve implantation in intermediate- and low-risk populations: An inevitable progression?
    Jabbour RJ; Pagnesi M; Kawamoto H; Tanaka A; Regazzoli D; Mangieri A; Ancona M; Monaco F; Agricola E; Spagnolo P; Castiglioni A; De Angelis G; Chieffo A; Montorfano M; Colombo A; Latib A
    Int J Cardiol; 2016 May; 210():35-7. PubMed ID: 26922711
    [No Abstract]   [Full Text] [Related]  

  • 19. Aortic Valve Replacement With Carpentier-Edwards: Hemodynamic Outcomes for the 19-mm Valve.
    You JH; Jeong DS; Sung K; Kim WS; Carriere KC; Lee YT; Park PW
    Ann Thorac Surg; 2016 Jun; 101(6):2209-16. PubMed ID: 26872735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and major adverse cardiovascular events after transcatheter aortic valve replacement using Edwards valve versus CoreValve: A meta-analysis.
    Panchal HB; Barry N; Bhatheja S; Albalbissi K; Mukherjee D; Paul T
    Cardiovasc Revasc Med; 2016; 17(1):24-33. PubMed ID: 26718733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.